Updated CCSG Guidelines on Agenda for CRI Meeting
Set for July 12-13, in Chicago, the 9th Annual AACI Clinical Research Initiative Meeting will feature a panel discussion on "Updated Cancer Center Support Grant Guidelines". Presenters will discuss revisions to the grant guidelines and instructions for renewing the P30 grant. In addition, attendees will hear about lessons learned and practical advice from two centers that have recently completed their CCSG competing renewal under the new guidelines.
Information on the meeting, including the program and electronic registration is available on the AACI CRI meeting website
. Please contact Jaime Anderson
with questions. Potential sponsors should contact Kate Burroughs
at 412-647-3844 regarding commercial support opportunities.
The CRI annual meeting program aligns with AACIs strategic goal of stimulating cancer center interactions to maximize the use of resources, including eliminating unproductive steps which slow down the drug development process. Those involved in CRI fill a variety of leadership roles and possess a comprehensive understanding of their centers entire clinical trials system. This years meeting theme focuses on how AACI cancer centers are adapting to manage novel and complex cancer clinical research trials which advance cancer treatment and prolong patient survival.
1. Address cancer center challenges by working with novel research agents that can lead to the rapid development of new therapies.
2. Discuss how clinical trials office leaders are changing their operational structures to adapt to complex trial designs like the NCI Match Trial and basket and umbrella type trials.
3. Describe the impact of revisions to the NCI Cancer Center Support Grant guidelines, including how they affect preparations for NCI site visits.
4. Support peer-to-peer networking, collaboration and ongoing communications between clinical trials office administrative and medical directors.
5. Identify policies and practices that promote staff retention, job satisfaction, diversity and stability for the cancer center clinical research workforce.
6. Highlight challenges in preparing for audits and site monitoring visits.
7. Create trial budgets that address research staff effort while adhering to National Trial Coverage Decision Guidelines.
8. Discuss how cancer centers are building relationships with network care sites to promote trial accrual, coordination and monitoring to ensure study compliance and accurate research data collection that aligns with study endpoints.
9. Explore the use of information technology platforms to facilitate research data collection, electronic regulatory record management, and the capture of clinical trial finances.
Who Should Attend This Meeting?
Administrative Directors of Clinical Trials Offices
Clinical Trials Office Medical Directors
Deputy/Associate Directors of Clinical Research Administration
Administrative Directors of the Clinical Trials Office
Cancer Center Administrators
Clinical Trials Office Managers and Supervisors
Research Regulatory Agency Organization Employees
AACI Sustaining Members
AACI Corporate Roundtable Members
Representatives from industry including pharmaceutical companies and clinical research organizations